How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond

J Rimando, SR McCurdy, L Luznik - Blood, 2023 - ashpublications.org
Advances in conditioning, graft-versus-host disease (GVHD) prophylaxis and antimicrobial
prophylaxis have improved the safety of allogeneic hematopoietic cell transplantation (HCT) …

Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients

S Jodele, A Sabulski - Expert Review of Hematology, 2021 - Taylor & Francis
Introduction Hematopoietic stem cell transplantation-associated thrombotic microangiopathy
(TA-TMA) is a severe complication of transplant. TA-TMA is a multifactorial disease where …

Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias

JC Fierro-Pineda, HL Tsai, A Blackford… - Blood …, 2023 - ashpublications.org
Promising results have been reported for adult patients with high-risk hematologic
malignancies undergoing haploidentical bone marrow transplant (haploBMT) with …

[HTML][HTML] Systematic review of signs and symptoms associated with hematopoietic stem cell transplantation-associated thrombotic microangiopathy

CE Dandoy, WH Tsong, K Sarikonda… - … and Cellular Therapy, 2023 - Elsevier
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-
TMA) is a serious complication of the transplantation process that has been consistently …

Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults

S Vasu, M Bostic, Q Zhao, N Sharma, M Puto… - Blood …, 2022 - ashpublications.org
Hematopoietic cell transplantation–associated thrombotic microangiopathy (TMA) is a
complication associated with higher nonrelapse mortality (NRM) in patients who undergo …

Comparison of multiple treatments in the management of transplant-related thrombotic microangiopathy: a network meta-analysis

J Yang, X Xu, S Han, J Qi, X Li, T Pan, R Zhang… - Annals of …, 2023 - Springer
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA) is
a fatal post-transplant complication. It has a high mortality rate and worse prognosis, but …

Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies

ML Fox, I García-Cadenas, V Navarro… - Bone Marrow …, 2024 - nature.com
Despite novel cellular and immunomodulatory therapies, allogeneic hematopoietic stem cell
transplantation (HSCT) remains a treatment option for lymphoid malignancies. Post …

Transplant-associated thrombotic microangiopathy in pediatrics: incidence, risk factors, therapeutic options, and outcome based on data from a single center

K Kafa, JI Hoell - Frontiers in Oncology, 2024 - pmc.ncbi.nlm.nih.gov
Background Transplant-associated thrombotic microangiopathy (TA-TMA) is a critical
complication of hematopoietic stem cell transplantation. Awareness about TA-TMA has …

Comparisons between frontline therapy and a combination of eltrombopag plus immunosuppression therapy and human leukocyte antigen-haploidentical …

Y Yang, J Ji, Z Tang, B Han - Frontiers in oncology, 2021 - frontiersin.org
Background and Aims: This study aimed at comparing the efficacy and safety of eltrombopag
(EPAG) plus immunosuppressive therapies (ISTs) and haploidentical hematopoietic stem …

[PDF][PDF] КЛИНИКО-ФУНКЦИОНАЛЬНОЕ СОСТОЯНИЕ ПОЧЕК У БОЛЬНЫХ С ОСТРЫМ ЛЕЙКОЗОМ ПОСЛЕ ТРАНСПЛАНТАЦИИ КОСТНОГО МОЗГА

ИМ Азимбаева - Science, 2022 - researchgate.net
Результаты и выводы: Анализ данных литературы показал, что повреждение почек
является частым явлением после трансплантации костного мозга. Повреждение почек …